Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Status:
Not yet recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to assess the treatment efficacy of a single high dose of
psilocybin administered within a protocol of psychological support to patients diagnosed with
alcohol use disorder (AUD).
Phase:
Phase 2
Details
Lead Sponsor:
Anders Fink-Jensen, MD, DMSci
Collaborator:
The Neurobiology Research Unit at Copenhagen University Hospital Rigshospitalet